BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36634491)

  • 21. The secretome of mesenchymal stem cells and oxidative stress: challenges and opportunities in cell-free regenerative medicine.
    Rahimi B; Panahi M; Saraygord-Afshari N; Taheri N; Bilici M; Jafari D; Alizadeh E
    Mol Biol Rep; 2021 Jul; 48(7):5607-5619. PubMed ID: 34191238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease.
    Driscoll J; Patel T
    J Gastroenterol; 2019 Sep; 54(9):763-773. PubMed ID: 31270691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone Marrow-Mesenchymal Stromal Cell Secretome as Conditioned Medium Relieves Experimental Skeletal Muscle Damage Induced by Ex Vivo Eccentric Contraction.
    Squecco R; Tani A; Chellini F; Garella R; Idrizaj E; Rosa I; Zecchi-Orlandini S; Manetti M; Sassoli C
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Potency Assay for MSC Secretome-Based Treatment of Idiopathic Male Infertility Employed Leydig Cells and Revealed Vascular Endothelial Growth Factor as a Promising Potency Marker.
    Monakova A; Sagaradze G; Basalova N; Popov V; Balabanyan V; Efimenko A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a surrogate potency assay to determine the angiogenic activity of Stempeucel®, a pooled, ex-vivo expanded, allogeneic human bone marrow mesenchymal stromal cell product.
    Thej C; Ramadasse B; Walvekar A; Majumdar AS; Balasubramanian S
    Stem Cell Res Ther; 2017 Feb; 8(1):47. PubMed ID: 28245882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-Conditioning with IFN-γ and Hypoxia Enhances the Angiogenic Potential of iPSC-Derived MSC Secretome.
    Wang S; Umrath F; Cen W; Salgado AJ; Reinert S; Alexander D
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minicircle-based expression of vascular endothelial growth factor in mesenchymal stromal cells from diverse human tissues.
    Serra J; Alves CPA; Cabral JMS; Monteiro GA; da Silva CL; Prazeres DMF
    J Gene Med; 2021 Jul; 23(7):e3342. PubMed ID: 33870576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-delivery of NS1 and BMP2 mRNAs to murine pluripotent stem cells leads to enhanced BMP-2 expression and osteogenic differentiation.
    Wang P; Logeart-Avramoglou D; Petite H; Goncalves C; Midoux P; Perche F; Pichon C
    Acta Biomater; 2020 May; 108():337-346. PubMed ID: 32251783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing inflammatory and chemotactic signals to regulate bone regeneration.
    Czekanska EM; Ralphs JR; Alini M; Stoddart MJ
    Eur Cell Mater; 2014 Oct; 28():320-34. PubMed ID: 25340809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioactive decellularized cardiac extracellular matrix-based hydrogel as a sustained-release platform for human adipose tissue-derived stromal cell-secreted factors.
    Liguori TTA; Liguori GR; van Dongen JA; Moreira LFP; Harmsen MC
    Biomed Mater; 2021 Feb; 16(2):025022. PubMed ID: 33264764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine.
    L PK; Kandoi S; Misra R; S V; K R; Verma RS
    Cytokine Growth Factor Rev; 2019 Apr; 46():1-9. PubMed ID: 30954374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of mesenchymal stromal cell (MSC)-derived soluble proteins and extracellular vesicles (EVs).
    Gorgun C; Ceresa D; Lesage R; Villa F; Reverberi D; Balbi C; Santamaria S; Cortese K; Malatesta P; Geris L; Quarto R; Tasso R
    Biomaterials; 2021 Feb; 269():120633. PubMed ID: 33453634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HATMSC Secreted Factors in the Hydrogel as a Potential Treatment for Chronic Wounds-In Vitro Study.
    Kraskiewicz H; Hinc P; Krawczenko A; Bielawska-Pohl A; Paprocka M; Witkowska D; Mohd Isa IL; Pandit A; Klimczak A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Priming Dental Pulp Stem Cells With Fibroblast Growth Factor-2 Increases Angiogenesis of Implanted Tissue-Engineered Constructs Through Hepatocyte Growth Factor and Vascular Endothelial Growth Factor Secretion.
    Gorin C; Rochefort GY; Bascetin R; Ying H; Lesieur J; Sadoine J; Beckouche N; Berndt S; Novais A; Lesage M; Hosten B; Vercellino L; Merlet P; Le-Denmat D; Marchiol C; Letourneur D; Nicoletti A; Vital SO; Poliard A; Salmon B; Muller L; Chaussain C; Germain S
    Stem Cells Transl Med; 2016 Mar; 5(3):392-404. PubMed ID: 26798059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells and Their Contribution to Angiogenic Processes in Tissue Regeneration.
    Krawczenko A; Klimczak A
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-92a regulates angiogenic activity of adipose-derived mesenchymal stromal cells.
    Kalinina N; Klink G; Glukhanyuk E; Lopatina T; Efimenko A; Akopyan Z; Tkachuk V
    Exp Cell Res; 2015 Nov; 339(1):61-6. PubMed ID: 26477824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hierarchical microchanneled scaffolds modulate multiple tissue-regenerative processes of immune-responses, angiogenesis, and stem cell homing.
    Won JE; Lee YS; Park JH; Lee JH; Shin YS; Kim CH; Knowles JC; Kim HW
    Biomaterials; 2020 Jan; 227():119548. PubMed ID: 31670033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem cells as drug delivery methods: application of stem cell secretome for regeneration.
    Tran C; Damaser MS
    Adv Drug Deliv Rev; 2015 Mar; 82-83():1-11. PubMed ID: 25451858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
    Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
    Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.
    Ferreira JR; Teixeira GQ; Santos SG; Barbosa MA; Almeida-Porada G; Gonçalves RM
    Front Immunol; 2018; 9():2837. PubMed ID: 30564236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.